Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
Phase 1
- Conditions
- Amphetamine-Related Disorders
- Registration Number
- NCT00040040
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
- Detailed Description
This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Please contact site director for more details.
Exclusion Criteria
Please contact site director for more details.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Psychological effects BP, HR
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
University of Texas Health Science Center
🇺🇸Houston, Texas, United States
UCLA Integrated Substance Abuse Program
🇺🇸Los Angeles, California, United States